Trocoxil Back In Stock
Trocoxil, the only once monthly treatment for canine osteoarthritis, is back in stock following a supply shortage. Zoetis have been working hard to ensure improved supply on a number of brands including Apoquel, Palladia and now Trocoxil, with animal welfare being the key consideration at all times throughout this process.
Ned Flaxman, business unit director for companion animal, equine and innovation at Zoetis comments: “It was a really difficult decision to stop production of Trocoxil in favour of Apoquel and Palladia but we felt that it was the right thing to do on animal welfare grounds. As soon as we had full stocks of these products we resumed the manufacture of Trocoxil and I am delighted to say that it will be back in stock in December.
“I would like to thank our veterinary clients for their patience and reassure them that we brought the product back to market as quickly as we could and do not anticipate any further stock issues.”
Trocoxil chewable tablets are used for the treatment of pain and inflammation associated with degenerative joint disease in dogs aged 12 months or over.
For more information on Trocoxil please contact your Zoetis account manager.
More from Zoetis
- Vets encouraged to talk to farmers about season long worm and fly control in cattle
- Zoetis renews partnership with BVNA
- Zoetis Introduces Equine Parasite Control Masterclass Webinar Series
- 93% of horse owners would vaccinate for EHV if their vet recommended it
- Zoetis calls vets to help test groundbreaking equine health-related quality of life (HRQL) assessment tool
9 years ago
2278 views

6 days ago